Sign in

IMCC on Nasdaq

IM Cannabis Corp.

IM Cannabis Corp. is a Canadian medicinal chemicals and botanical products company.1 Its shares trade on Nasdaq under the symbol IMCC.1

Price unavailable

Last updated Oct 21, 2026.

Overview

54.7MRevenue, fiscal 20252
-11.8MNet income, fiscal 20252

Compare with Aurora Cannabis, Canopy Growth Corporation or SNDL Inc., or pick any stock.

  • TickerIMCC on Nasdaq1
  • IndustryMedicinal Chemicals & Botanical Products1
  • HeadquartersA11
  • Incorporated inBritish Columbia, Canada3
  • Business addressKibbutz Glil Yam, Central District, L3 46905003
  • Filer categoryNon-accelerated filer, Emerging growth company3
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Our Common Shares and certain warrants previously traded on the Canadian Securities Exchange (the “CSE”) until June 2, 2025.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.

Key numbers, fiscal 2025

17.7%Gross margin2
-21.2%Operating margin2
-21.5%Net margin2
1.3%Revenue growth, 20252
4.7M CADFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Cannabis Products brought in 97% of the revenue IM Cannabis Corp. broke down this way in fiscal 2025.

  1. Cannabis Products53.2M CAD297%up 4% from 2024
  2. Other Cannabis1.5M CAD23%down 43% from 2024
Products and services by year
Products and services202320242025
Cannabis Products44.2M CAD51.3M CAD53.2M CAD
Other Cannabis4.6M CAD2.7M CAD1.5M CAD

Regions

Foreign countries [member] brought in 66% of the revenue IM Cannabis Corp. broke down this way in fiscal 2025.

  1. Foreign countries [member]36.3M CAD266%up 134% from 2024
  2. Country of domicile [member]18.4M CAD234%down 52% from 2024
Regions by year
Regions202320242025
Foreign countries [member]5.5M CAD15.5M CAD36.3M CAD
Country of domicile [member]43.3M CAD38.5M CAD18.4M CAD

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue82¢45.0M CAD
  • Other costs11¢6.1M CAD
  • Interest6¢3.5M CAD
  • Income tax0¢92.0K CAD

Out of 54.7M CAD in revenue.2 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending0¢13.0K CAD
  • Kept or used elsewhere100¢4.7M CAD

Out of 4.7M CAD of cash from operations.2

Financial statements

Revenue5678254.7M CAD in 2025+503% since 2019
020.0M CAD40.0M CAD60.0M CAD2019: 9.1M CAD9.1M CAD20192020: 15.9M CAD15.9M CAD2020+75%2021: 34.1M CAD34.1M CAD2021+114%2022: 54.3M CAD54.3M CAD2022+60%2023: 48.8M CAD48.8M CAD2023−10%2024: 54.0M CAD54.0M CAD2024+11%2025: 54.7M CAD54.7M CAD2025+1%
Gross profit567829.7M CAD in 2025+147% since 2019
05.0M CAD10.0M CAD15.0M CAD2019: 3.9M CAD3.9M CAD20192020: 10.5M CAD10.5M CAD2020+166%2021: 6.3M CAD6.3M CAD2021−40%2022: 9.2M CAD9.2M CAD2022+45%2023: 9.8M CAD9.8M CAD2023+7%2024: 8.5M CAD8.5M CAD2024−14%2025: 9.7M CAD9.7M CAD2025+15%
Operating income56782-11.6M CAD in 2025+13% since 2019
-40.0M CAD-30.0M CAD-20.0M CAD-10.0M CAD02019: -10.3M CAD-10.3M CAD20192020: -8.2M CAD-8.2M CAD2020−20%2021: -23.0M CAD-23.0M CAD2021+179%2022: -30.8M CAD-30.8M CAD2022+34%2023: -12.8M CAD-12.8M CAD2023−58%2024: -10.2M CAD-10.2M CAD2024−20%2025: -11.6M CAD-11.6M CAD2025+13%
Net income56782-11.8M CAD in 2025+58% since 2019
-200.0M CAD-150.0M CAD-100.0M CAD-50.0M CAD02019: -7.4M CAD-7.4M CAD20192020: -28.7M CAD-28.7M CAD2020+287%2021: -18.5M CAD-18.5M CAD2021−36%2022: -191.3M CAD-191.3M CAD2022+933%2023: -10.2M CAD-10.2M CAD2023−95%2024: -11.8M CAD-11.8M CAD2024+15%2025: -11.8M CAD-11.8M CAD2025−0%

Every line of the income statement as filed: the last 3 fiscal years, latest first.2

Period ending2025-12-312024-12-312023-12-31
Revenue54.7M CAD54.0M CAD48.8M CAD
Cost of revenue45.0M CAD45.6M CAD38.0M CAD
Gross profit before fair value adjustments9.7M CAD8.5M CAD10.8M CAD
Realized fair value adjustments on inventory sold or impaired0 CAD0 CAD-984.0K CAD
Total fair value adjustments0 CAD0 CAD-984.0K CAD
Gross profit after fair value adjustments9.7M CAD8.5M CAD9.8M CAD
Selling and marketing expenses5.4M CAD7.1M CAD10.8M CAD
General and administrative expenses9.5M CAD8.0M CAD11.0M CAD
Restructuring expenses0 CAD0 CAD617.0K CAD
Other expenses6.4M CAD3.2M CAD0 CAD
Share-based compensation14.0K CAD369.0K CAD225.0K CAD
Total operating expenses21.3M CAD18.7M CAD22.6M CAD
Operating loss-11.6M CAD-10.2M CAD-12.8M CAD
Finance income3.4M CAD2.2M CAD7.0M CAD
Finance expenses-3.5M CAD-4.8M CAD-3.7M CAD
Finance income (expense), net-71.0K CAD-2.6M CAD3.3M CAD
Loss before taxes on income (tax benefit)-11.7M CAD-12.8M CAD-9.5M CAD
Taxes on income (tax benefit)92.0K CAD-1.0M CAD771.0K CAD
Net loss-11.8M CAD-11.8M CAD-10.2M CAD
Remeasurement gain on defined benefit plans48.0K CAD67.0K CAD38.0K CAD
Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods48.0K CAD67.0K CAD38.0K CAD
Adjustments arising from translation of financial statements of foreign operations-2.5M CAD-1.5M CAD-663.0K CAD
Total other comprehensive loss-2.4M CAD-1.4M CAD-625.0K CAD
Shareholders of the Company-11.3M CAD-10.6M CAD-9.5M CAD
Non-controlling interests-431.0K CAD-1.2M CAD-730.0K CAD
Shareholders of the Company-13.8M CAD-11.9M CAD-10.6M CAD
Non-controlling interests-346.0K CAD-1.3M CAD-205.0K CAD
Total comprehensive loss-14.2M CAD-13.2M CAD-10.9M CAD
Basic loss per share (in CAD)-2.67 CAD-4.51 CAD-4.45 CAD
Diluted loss per share (in CAD)-2.67 CAD-4.51 CAD-4.45 CAD

Compare IM Cannabis Corp. with another company

Corporate structure

IM Cannabis Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of IM Cannabis Corp.

  • Invest Pro Shukai Hon Ltd. Filed SCHEDULE 13G on IM Cannabis Corp., latest Sep 30, 2026
  • L.I.A. Pure Capital Ltd Filed SCHEDULE 13G on IM Cannabis Corp., latest Sep 30, 2026
  • Nissim Daniel Filed SCHEDULE 13G on IM Cannabis Corp., latest Sep 30, 2026
  • Luminera Derm Ltd. Filed SC 13G on IM Cannabis Corp., latest Feb 21, 2023
  • Oren Shuster Filed SC 13D/A on IM Cannabis Corp., latest Feb 8, 2023 (2 filings since Feb 14, 2022)
  • Rafael Rifat Gabay Filed SC 13G/A on IM Cannabis Corp., latest Feb 2, 2023 (2 filings since Feb 16, 2022)
  • IM Cannabis Corp. A1

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What IM Cannabis Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net3.7M CAD2 Dec 31, 20253.7M CAD2 Dec 31, 2024−0.5%
Operating-lease assets (leased space)401.0K CAD2 Dec 31, 2025451.0K CAD2 Dec 31, 2024−11.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents2.7M CAD2 Dec 31, 2025863.0K CAD2 Dec 31, 2024+216.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill1.9M CAD2 Dec 31, 20256.7M CAD2 Dec 31, 2024−71.8%
Intangible assets, net (excluding goodwill)1.2M CAD2 Dec 31, 20253.3M CAD2 Dec 31, 2024−63.3%

Inventory

ItemLatestA year beforeChange
Inventory, total4.3M CAD2 Dec 31, 20253.2M CAD2 Dec 31, 2024+32.8%

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerMichal Lebovitz Nissimov named Nov 20, 202410
  • Executive Officer, DirectorOren Shuster named Nov 20, 202410
  • Executive OfficerRichard Balla named Nov 20, 202410
  • Executive OfficerUri Birenberg named Nov 20, 202410
  • DirectorBrian Schinderle named Nov 20, 202410
  • DirectorEinat Zakariya named Nov 20, 202410
  • DirectorMoti Marcus named Nov 20, 202410
  • DirectorShmulik Arbel named Nov 20, 202410

Calendar

Coming up

  1. Nov 12, 2026Reports results for the quarter ending Sep/202611

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

248 filings to the SEC since October 2021: 6 annual reports, 8 large holders, 1 private raises, 233 other. The latest 20:

  1. Oct 8, 2026F-3 EDGAR
  2. Oct 2, 20266-K EDGAR
  3. Sep 30, 2026SCHEDULE 13G EDGAR
  4. Sep 30, 2026SCHEDULE 13G EDGAR
  5. Sep 30, 2026SCHEDULE 13G EDGAR
  6. Sep 28, 20266-K EDGAR
  7. Sep 25, 20266-K EDGAR
  8. Sep 24, 2026424B5 EDGAR
  9. Sep 24, 20266-K EDGAR
  10. Sep 23, 20266-K EDGAR
  11. Sep 23, 20266-K EDGAR
  12. Sep 2, 20266-K EDGAR
  13. Aug 27, 20266-K EDGAR
  14. Aug 18, 20266-K EDGAR
  15. Aug 17, 20266-K EDGAR
  16. Aug 13, 20266-K EDGAR
  17. Aug 7, 20266-K EDGAR
  18. Jul 27, 20266-K EDGAR
  19. Jul 1, 20266-K EDGAR
  20. Jun 18, 20266-K EDGAR

The 248 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Nov 12, 2024Raised $26,893 in a private offering of equity Form D: $67,234 offered in all Form D

SEC filer profile

How IM Cannabis Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARIM Cannabis Corp.1
  • CIK0001792030
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inCanada4
  • Fiscal year endsDecember 311
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business addressKibbutz Glil Yam, Central District, L3 46905001
  • Phone416-256-42021
  • Shares outstanding5,894,812 shares as of Dec 31, 20254
  • AuditorFAHN KANNE & CO. GRANT THORNTON ISRAEL, Tel Aviv, Israel PCAOB ID 1375; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceOct 24, 20191
  • Filings300 in all: 6-K (245), CORRESP (6), UPLOAD (6), D (5), EFFECT (5), F-3 (5), 20-F (4), SCHEDULE 13G (3)1
    All 25 form types

    40-F (2), F-X (2), SC 13G (2), SUPPL (2), 20-F/A (1), 40-F/A (1), 40FR12B (1), 424B5 (1), 6-K/A (1), CERT (1), F-10 (1), F-10/A (1), F-3/A (1), SC 13D (1), SC 13D/A (1), SC 13G/A (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (20-F) Mar 30, 2026

Securities registered for trading

ClassSymbolExchange
Common SharesIMCCNasdaq

From the cover page of the 20-F filed Mar 30, 2026 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17